4//SEC Filing
Doyle John Brendan 4
Accession 0001062993-24-003651
CIK 0001455365other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:13 PM ET
Size
7.1 KB
Accession
0001062993-24-003651
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-15+20,000→ 129,824 total - Award
Stock Option (Right to Buy)
2024-02-15+20,000→ 20,000 totalExercise: $1.98Exp: 2034-02-15→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.
Issuer
COGNITION THERAPEUTICS INC
CIK 0001455365
Entity typeother
Related Parties
1- filerCIK 0001840738
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:13 PM ET
- Size
- 7.1 KB